Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.77 - $3.09 $270 - $472
-153 Reduced 0.86%
17,735 $33,000
Q4 2023

Feb 13, 2024

BUY
$1.72 - $3.1 $1,100 - $1,984
640 Added 3.71%
17,888 $47,000
Q3 2023

Nov 13, 2023

BUY
$2.23 - $4.69 $1,366 - $2,874
613 Added 3.69%
17,248 $39,000
Q2 2023

Aug 04, 2023

BUY
$3.11 - $4.91 $51,734 - $81,677
16,635 New
16,635 $60,000
Q2 2022

Aug 12, 2022

SELL
$2.49 - $5.92 $38,027 - $90,410
-15,272 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.41 - $12.28 $4,745 - $13,213
-1,076 Reduced 6.58%
15,272 $75,000
Q4 2021

Feb 11, 2022

SELL
$10.86 - $17.85 $5,299 - $8,710
-488 Reduced 2.9%
16,348 $185,000
Q3 2021

Nov 12, 2021

BUY
$10.06 - $15.3 $1,519 - $2,310
151 Added 0.91%
16,836 $245,000
Q2 2021

Aug 13, 2021

SELL
$10.9 - $14.53 $5,777 - $7,700
-530 Reduced 3.08%
16,685 $194,000
Q1 2021

May 07, 2021

BUY
$11.2 - $16.09 $515 - $740
46 Added 0.27%
17,215 $210,000
Q4 2020

Feb 12, 2021

SELL
$11.12 - $16.4 $400 - $590
-36 Reduced 0.21%
17,169 $215,000
Q3 2020

Nov 04, 2020

BUY
$15.05 - $23.54 $3,702 - $5,790
246 Added 1.45%
17,205 $259,000
Q2 2020

Aug 12, 2020

BUY
$12.7 - $30.73 $65,303 - $158,013
5,142 Added 43.51%
16,959 $416,000
Q1 2020

May 04, 2020

SELL
$9.85 - $22.27 $6,727 - $15,210
-683 Reduced 5.46%
11,817 $168,000
Q4 2019

Feb 05, 2020

BUY
$7.06 - $17.47 $854 - $2,113
121 Added 0.98%
12,500 $198,000
Q3 2019

Nov 08, 2019

BUY
$6.78 - $9.28 $6,149 - $8,416
907 Added 7.91%
12,379 $104,000
Q2 2019

Aug 13, 2019

SELL
$7.18 - $9.65 $840 - $1,129
-117 Reduced 1.01%
11,472 $103,000
Q1 2019

May 06, 2019

SELL
$4.7 - $9.29 $225 - $445
-48 Reduced 0.41%
11,589 $90,000
Q4 2018

Feb 13, 2019

SELL
$4.35 - $8.73 $391 - $785
-90 Reduced 0.77%
11,637 $55,000
Q3 2018

Nov 09, 2018

BUY
$7.91 - $11.89 $1,669 - $2,508
211 Added 1.83%
11,727 $106,000
Q2 2018

Aug 08, 2018

BUY
$10.93 - $14.48 $63,601 - $84,259
5,819 Added 102.14%
11,516 $137,000
Q1 2018

May 07, 2018

BUY
$11.63 - $17.25 $66,256 - $98,273
5,697 New
5,697 $80,000

Others Institutions Holding CUE

About Cue Biopharma, Inc.


  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $38.2M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.